GSK Loses Patent Over Lung Disease Treatment At EPO
A European appeals panel has stripped a GSK subsidiary of its patent over a steroid that helps treat lung disease, ruling that the medicine isn't inventive over a 2008 study of...To view the full article, register now.
Already a subscriber? Click here to view full article